What is Lederman and Lederman?
Lederman and Lederman, LLP operates as a premier clinical entity specializing in Pediatric Ophthalmology, Pediatric Cataract Surgery, and Adult Strabismus. The firm distinguishes itself through a patient-centric model that integrates advanced surgical techniques with a compassionate, child-friendly environment. By maintaining collaborative relationships with world-class medical facilities and specialized consultants, the practice provides a comprehensive continuum of care. Their commitment to clear, transparent communication regarding complex diagnoses and treatment pathways has established them as a trusted authority in the field of pediatric vision health.
How much funding has Lederman and Lederman raised?
Lederman and Lederman has raised a total of $330K across 2 funding rounds:
Debt
$150K
Debt
$180K
Debt (2020): $150K with participation from PPP
Debt (2021): $180K led by PPP
Key Investors in Lederman and Lederman
PPP
Public-Private Partnership
What's next for Lederman and Lederman?
With the successful acquisition of this late-stage capital, Lederman and Lederman is well-positioned to scale its clinical operations and enhance its technological capabilities. The strategic deployment of these funds will likely focus on the integration of next-generation diagnostic tools and the expansion of surgical suites to accommodate a growing patient base. As the firm navigates this growth phase, the focus remains on maintaining the high standard of care that defines their practice while exploring new avenues for medical research and collaborative treatment protocols. This financial milestone serves as a catalyst for long-term sustainability and continued excellence in the specialized domain of pediatric ophthalmology.
See full Lederman and Lederman company page
